✦ LIBER ✦

A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination

✍ Scribed by Ramesh K. Ramanathan; James Abbruzzese; Tomislav Dragovich; Lynn Kirkpatrick; Jose M. Guillen; Amanda F. Baker; Linda A. Pestano; Sylvan Green; Daniel D. Von Hoff

Publisher: Springer
Year: 2010
Tongue: English
Weight: 267 KB
Volume: 67
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-010-1343-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II, randomized, blinded study of

A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy

✍ Stephen R. D. Johnston; Vladimir F. Semiglazov; George M. Manikhas; Dominique Sp 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 180 KB

A phase II, randomized, multicenter stud

A phase II, randomized, multicenter study to assess the efficacy, safety, and tolerability of zibotentan (ZD4054) in combination with pemetrexed in patients with advanced non-small cell lung cancer

✍ Christos Chouaid; Faith Nathan; Kristine Pemberton; Thomas Morris 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 244 KB